John M S Bartlett

发表

Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer

Deena M A Gendoo, Robert E Denroche, Amy Zhang, 2017, bioRxiv.

Pathway-based subnetworks enable cross-disease biomarker discovery

Pietro Lio', John M S Bartlett, Philippe Lambin, 2018, Nature Communications.

Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training

John M S Bartlett, Robert C Stein, Tammy Piper, 2020, PloS one.

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration

John M S Bartlett, Indu Arun, Mitch Dowsett, 2016, npj Breast Cancer.

Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients

John M S Bartlett, David Cameron, Chris Twelves, 2009, Clinical Cancer Research.

HER2 testing: current status and future directions.

John M S Bartlett, Edith A Perez, E. Perez, 2014, Cancer treatment reviews.

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.

John M S Bartlett, Hein Putter, Cornelis J H van de Velde, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The androgen receptor and signal‐transduction pathways in hormone‐refractory prostate cancer. Part 2: androgen‐receptor cofactors and bypass pathways

John M S Bartlett, J. Bartlett, J. Edwards, 2005, BJU international.

ISOWN: accurate somatic mutation identification in the absence of normal tissue controls

John M S Bartlett, Irina Kalatskaya, John D McPherson, 2017, Genome Medicine.

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

John M S Bartlett, Patrick Fitzgibbons, Lisa M McShane, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

John M S Bartlett, Christopher McCabe, Nigel Stallard, 2016, Health technology assessment.

An international Ki67 reproducibility study.

John M S Bartlett, Mitch Dowsett, Lisa M McShane, 2013, Journal of the National Cancer Institute.

Updated UK Recommendations for HER2 assessment in breast cancer

John M S Bartlett, Andrew Hanby, Elena Provenzano, 2014, Journal of Clinical Pathology.

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

John M S Bartlett, Patrick Fitzgibbons, Mitch Dowsett, 2014, Archives of pathology & laboratory medicine.

The androgen receptor and signal‐transduction pathways in hormone‐refractory prostate cancer. Part 1: modifications to the androgen receptor

John M S Bartlett, J. Bartlett, J. Edwards, 2005, BJU international.

Ductal carcinoma in situ of the breast: can biomarkers improve current management?

John M S Bartlett, J. Bartlett, E. Rakovitch, 2014, Clinical chemistry.

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

John M S Bartlett, Patrick Fitzgibbons, Mitch Dowsett, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial.

John M S Bartlett, Hein Putter, Cornelis J H van de Velde, 2016, Archives of pathology & laboratory medicine.

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

John M S Bartlett, Patrick Fitzgibbons, Lisa M McShane, 2018, Archives of pathology & laboratory medicine.

An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer

John M S Bartlett, Liron Pantanowitz, Carsten Denkert, 2018, Modern Pathology.

Histological grading of invasive breast carcinoma – a simplification of existing methods in a large conservation series with long‐term follow‐up

John M S Bartlett, G. Kerr, U. Chetty, 2009, Histopathology.

An international study to increase concordance in Ki67 scoring

John M S Bartlett, Mitch Dowsett, Lisa M McShane, 2015, Modern Pathology.

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.

John M S Bartlett, Guido Sauter, G. Sauter, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biomarkers and patient selection for PI3K/Akt/mTOR targeted therapies: current status and future directions.

John M S Bartlett, J. Bartlett, 2010, Clinical breast cancer.